Literature DB >> 24902975

Reperfusion strategies in acute coronary syndromes.

Akshay Bagai1, George D Dangas2, Gregg W Stone2, Christopher B Granger2.   

Abstract

The appropriate timing of angiography to facilitate revascularization is essential to optimize outcomes in patents with ST-segment-elevation myocardial infarction and non-ST-segment-elevation acute coronary syndromes. Timely reperfusion of the infarct-related coronary artery in ST-segment-elevation myocardial infarction both with fibrinolysis or percutaneous coronary intervention minimizes myocardial damage, reduces infarct size, and decreases morbidity and mortality. Primary percutaneous coronary intervention is the preferred reperfusion method if it can be performed in a timely manner. Strategies to reduce health system-related delays in reperfusion include regionalization of ST-segment-elevation myocardial infarction care, performing prehospital ECGs, prehospital activation of the catheterization laboratory, bypassing geographically closer nonpercutaneous coronary intervention-capable hospitals, bypassing the percutaneous coronary intervention-capable hospital emergency department, and early and consistent availability of the catheterization laboratory team. With implementation of such strategies, there has been significant improvement in process measures, including door-to-balloon time. However, despite reductions in door-to-balloon times, there has been little change during the past several years in in-hospital mortality, suggesting additional factors including patient-related delays, optimization of tissue-level perfusion, and cardioprotection must be addressed to improve patient outcomes further. Early angiography followed by revascularization when appropriate also reduces rates of death, MI, and recurrent ischemia in patients with non-ST-segment-elevation acute coronary syndromes, with the greatest benefits realized in the highest risk patients. Among patients with non-ST-segment-elevation acute coronary syndromes with multivessel disease, choice of revascularization modality should be made as in stable coronary artery disease, with a goal of complete ischemic revascularization.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  fibrinolysis; myocardial infarction; percutaneous coronary intervention; reperfusion

Mesh:

Year:  2014        PMID: 24902975     DOI: 10.1161/CIRCRESAHA.114.302744

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  34 in total

1.  Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.

Authors:  Shayne C Barlow; Heather Doviak; Julia Jacobs; Lisa A Freeburg; Paige E Perreault; Kia N Zellars; Karen Moreau; Camila F Villacreses; Stephen Smith; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-28       Impact factor: 4.733

Review 2.  PPARγ-Coactivator-1α, Nicotinamide Adenine Dinucleotide and Renal Stress Resistance.

Authors:  Ali Poyan Mehr; Samir M Parikh
Journal:  Nephron       Date:  2017-06-08       Impact factor: 2.847

Review 3.  Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review.

Authors:  Zaher Fanari; Sandra Weiss; William S Weintraub
Journal:  Am J Cardiovasc Drugs       Date:  2015-12       Impact factor: 3.571

4.  The spleen contributes importantly to myocardial infarct exacerbation during post-ischemic reperfusion in mice via signaling between cardiac HMGB1 and splenic RAGE.

Authors:  Yikui Tian; Dongfeng Pan; Mahendra D Chordia; Brent A French; Irving L Kron; Zequan Yang
Journal:  Basic Res Cardiol       Date:  2016-09-19       Impact factor: 17.165

5.  Mitochondrial phosphatase PGAM5 regulates Keap1-mediated Bcl-xL degradation and controls cardiomyocyte apoptosis driven by myocardial ischemia/reperfusion injury.

Authors:  Chen Yang; Xiaojuan Liu; Fangfang Yang; Weixun Zhang; Zihao Chen; Daliang Yan; Qingsheng You; Xiang Wu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-11-04       Impact factor: 2.416

6.  Cardiac Myocyte-specific Knock-out of Calcium-independent Phospholipase A2γ (iPLA2γ) Decreases Oxidized Fatty Acids during Ischemia/Reperfusion and Reduces Infarct Size.

Authors:  Sung Ho Moon; David J Mancuso; Harold F Sims; Xinping Liu; Annie L Nguyen; Kui Yang; Shaoping Guan; Beverly Gibson Dilthey; Christopher M Jenkins; Carla J Weinheimer; Attila Kovacs; Dana Abendschein; Richard W Gross
Journal:  J Biol Chem       Date:  2016-07-23       Impact factor: 5.157

7.  Heat shock protein 70 inhibits cardiomyocyte necroptosis through repressing autophagy in myocardial ischemia/reperfusion injury.

Authors:  Xiaojuan Liu; Chao Zhang; Chi Zhang; Jingjing Li; Wanwan Guo; Daliang Yan; Chen Yang; Jianhua Zhao; Tian Xia; Yuqing Wang; Rong Xu; Xiang Wu; Jiahai Shi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-29       Impact factor: 2.416

8.  Allicin attenuates myocardial apoptosis, inflammation and mitochondrial injury during hypoxia-reoxygenation: an in vitro study.

Authors:  Xinyi Deng; Peng Yang; Tong Gao; Mengru Liu; Xianlun Li
Journal:  BMC Cardiovasc Disord       Date:  2021-04-21       Impact factor: 2.298

9.  Bilateral Lung Artery Embolization Mimicking an Acute Myocardial Infarction.

Authors:  Maria Paparoupa; Razaz Aldemyati; Myrto Theodorakopoulou
Journal:  Case Rep Med       Date:  2021-06-15

Review 10.  Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip.

Authors:  Natalie N Khalil; Megan L McCain
Journal:  Front Cardiovasc Med       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.